179 related articles for article (PubMed ID: 25873590)
1. The dJ/dS Ratio Test Reveals Hundreds of Novel Putative Cancer Drivers.
Chen H; Xing K; He X
Mol Biol Evol; 2015 Aug; 32(8):2181-5. PubMed ID: 25873590
[TBL] [Abstract][Full Text] [Related]
2. Evolutionarily emerged G tracts between the polypyrimidine tract and 3' AG are splicing silencers enriched in genes involved in cancer.
Sohail M; Cao W; Mahmood N; Myschyshyn M; Hong SP; Xie J
BMC Genomics; 2014 Dec; 15(1):1143. PubMed ID: 25523808
[TBL] [Abstract][Full Text] [Related]
3. Cancer-mutation network and the number and specificity of driver mutations.
Iranzo J; Martincorena I; Koonin EV
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6010-E6019. PubMed ID: 29895694
[TBL] [Abstract][Full Text] [Related]
4. Discovery of driver non-coding splice-site-creating mutations in cancer.
Cao S; Zhou DC; Oh C; Jayasinghe RG; Zhao Y; Yoon CJ; Wyczalkowski MA; Bailey MH; Tsou T; Gao Q; Malone A; Reynolds S; Shmulevich I; Wendl MC; Chen F; Ding L
Nat Commun; 2020 Nov; 11(1):5573. PubMed ID: 33149122
[TBL] [Abstract][Full Text] [Related]
5. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
6. Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors.
Trigos AS; Pearson RB; Papenfuss AT; Goode DL
Proc Natl Acad Sci U S A; 2017 Jun; 114(24):6406-6411. PubMed ID: 28484005
[TBL] [Abstract][Full Text] [Related]
7. The U1 spliceosomal RNA is recurrently mutated in multiple cancers.
Shuai S; Suzuki H; Diaz-Navarro A; Nadeu F; Kumar SA; Gutierrez-Fernandez A; Delgado J; Pinyol M; López-Otín C; Puente XS; Taylor MD; Campo E; Stein LD
Nature; 2019 Oct; 574(7780):712-716. PubMed ID: 31597163
[TBL] [Abstract][Full Text] [Related]
8. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.
Wei PJ; Zhang D; Xia J; Zheng CH
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):467. PubMed ID: 28155630
[TBL] [Abstract][Full Text] [Related]
9. Network perturbation by recurrent regulatory variants in cancer.
Jang K; Kim K; Cho A; Lee I; Choi JK
PLoS Comput Biol; 2017 Mar; 13(3):e1005449. PubMed ID: 28333928
[TBL] [Abstract][Full Text] [Related]
10. Improving existing analysis pipeline to identify and analyze cancer driver genes using multi-omics data.
Nguyen QH; Le DH
Sci Rep; 2020 Nov; 10(1):20521. PubMed ID: 33239644
[TBL] [Abstract][Full Text] [Related]
11. Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas.
Tanimoto K; Muramatsu T; Inazawa J
Cancer Med; 2019 Dec; 8(17):7372-7384. PubMed ID: 31631560
[TBL] [Abstract][Full Text] [Related]
12. Integrative network-based approach identifies key genetic elements in breast invasive carcinoma.
Hamed M; Spaniol C; Zapp A; Helms V
BMC Genomics; 2015; 16 Suppl 5(Suppl 5):S2. PubMed ID: 26040466
[TBL] [Abstract][Full Text] [Related]
13. Systematic deciphering of cancer genome networks.
Fendler B; Atwal G
Yale J Biol Med; 2012 Sep; 85(3):339-45. PubMed ID: 23012582
[TBL] [Abstract][Full Text] [Related]
14. DJ-1 as a Therapeutic Target Against Cancer.
Cao J; Chen X; Ying M; He Q; Yang B
Adv Exp Med Biol; 2017; 1037():203-222. PubMed ID: 29147911
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of recurrent properties of cancer genes to identify novel drivers.
D'Antonio M; Ciccarelli FD
Genome Biol; 2013 May; 14(5):R52. PubMed ID: 23718799
[TBL] [Abstract][Full Text] [Related]
16. Depletion of somatic mutations in splicing-associated sequences in cancer genomes.
Hurst LD; Batada NN
Genome Biol; 2017 Nov; 18(1):213. PubMed ID: 29115978
[TBL] [Abstract][Full Text] [Related]
17. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive characterization of
Shiraishi Y; Kataoka K; Chiba K; Okada A; Kogure Y; Tanaka H; Ogawa S; Miyano S
Genome Res; 2018 Aug; 28(8):1111-1125. PubMed ID: 30012835
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
Brooks AN; Choi PS; de Waal L; Sharifnia T; Imielinski M; Saksena G; Pedamallu CS; Sivachenko A; Rosenberg M; Chmielecki J; Lawrence MS; DeLuca DS; Getz G; Meyerson M
PLoS One; 2014; 9(1):e87361. PubMed ID: 24498085
[TBL] [Abstract][Full Text] [Related]
20. Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing.
Krawczak M; Thomas NS; Hundrieser B; Mort M; Wittig M; Hampe J; Cooper DN
Hum Mutat; 2007 Feb; 28(2):150-8. PubMed ID: 17001642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
